Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PG-011 nasal spray for adults with moderate to severe seasonal allergic rhinitis
CTR20252915Phase 3Completed
- Sponsor
- Puqi Pharma
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pumecitinib in seasonal allergic rhinitis (SAR), sponsored by Puqi Pharma. Started Sep 2025; status: completed.
02
Drugs
pumecitinib
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on CTR20252915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252915.